Biondvax Pharmaceuticals Ltd.

Calculating rank

USPTO Granted Patents = 4

% Expired Patents = 50.0

CIPO Patents = 1

EPO Patents = 1

Trademarks = 2

Forward Citations = 12

Loading Chart...

7 inventors (with patents filed for the assignee):

Tamar Ben-Yedidia (3 out of 10 patents)

Yossi Singer (2 out of 2 patents)

Ram Uritski (1 out of 1 patent)

4. Barry Cohen (1 out of 1 patent)

5. Zohar Gadri (1 out of 1 patent)

6. Shimon Hassin (1 out of 1 patent)

7. George H Lowell (1 out of 1 patent)

4 patents: Sort by Forward Citations

1. 10426828 - Compositions of multimeric-multiepitope influenza polypeptides and their production (2019-10-01),

2. 9353159 - Multimeric multiepitope influenza vaccines (2016-05-31),

3. 9303070 - Multimeric multiepitope polypeptides in improved seasonal and pandemic influenza vaccines (2016-04-05),

4. 8747861 - Multimeric multiepitope influenza vaccines (2014-06-10),

Company Overview

Biondvax Pharmaceuticals Ltd. is a clinical-stage biopharmaceutical company focused on developing and commercializing innovative vaccines to prevent infectious diseases. Its lead product candidate, M-001, is a universal flu vaccine designed to provide multi-season and multi-strain protection. With a dedication to advancing public health through cutting-edge research and development, Biondvax is committed to improving global vaccine outcomes.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 27 2026

4 Patents

#21 in Ness Ziona

#1,417 in Israel

Ness Ziona, Israel

Biondvax Pharmaceuticals Ltd.

Forward Citations = 12

7 inventors:

Tamar Ben-Yedidia (3 out of 10 patents)

Yossi Singer (2 out of 2 patents)

Ram Uritski (1 out of 1 patent)

4. Barry Cohen (1 out of 1 patent)

5. Zohar Gadri (1 out of 1 patent)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Biondvax Pharmaceuticals Ltd.. Retrieved from https://idiyas.com/company/biondvax-pharmaceuticals

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

1 patent (CIPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

1 patent (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]